Cromos Pharma, where the patients are

Europe

GSK, Uppsala launch $140.6M European program targeting novel antibiotics

Wednesday, February 12, 2014 01:20 PM

Over 30 European universities, research institutes and companies, led by GlaxoSmithKline and Uppsala University, are joining forces in a six-year program supported by the Innovative Medicines Initiative (IMI) to develop novel antibiotics against Gram-negative pathogens in a project called ENABLE (European Gram-Negative Antibacterial Engine), including open calls for candidates outside the consortium.

More... »

CRF Health eCOA webinar series

Ulster launches a clinical research network for mental health

Thursday, February 6, 2014 11:47 AM

The University of Ulsterhas launched a dedicated Clinical Research Network for Northern Ireland. The new network means that mental health patients from Northern Ireland can now be involved in major national and international research trials. It also will ensure researchers and health professionals have a better understanding of mental health services.  

More... »


Wilex to implement cost-cutting, reduce workforce 80%

Friday, January 31, 2014 12:54 PM

Wilex, a biopharmaceutical company based in Munich, Germany, will implement extensive cost-cutting measures and focus on contract research and the ADC technology at its subsidiary Heidelberg Pharma. This decision was taken with the approval of the company's supervisory board.

More... »

Medigene acquires Trianta Immunotherapies

Wednesday, January 29, 2014 01:16 PM

Medigene, a biotechnology company headquartered in Martinsried, Germany, has acquired Munich-based Trianta Immunotherapies, recently spun out from the Munich Helmholtz Center.

More... »

LifeSciencesUK: Strategy of U.K. Life Sciences has more to accomplish

Friday, January 24, 2014 11:45 AM

A review of the government's Strategy for U.K. Life Sciences has found eight out of the 13 initiatives reviewed have made notable progress toward the actions and commitments set out in the original strategy, but there is still much more work to do to meet the strategy's original objectives.

More... »

Former U.K. AstraZeneca R&D site to become science, technology park

Monday, January 20, 2014 11:56 AM

Loughborough, U.K., will be the location for a world-class science and technology park as development of a former AstraZeneca R&D site gets underway. Jayplas acquired the site in 2012 and has confirmed its plans to develop the site into a science park to be known as The Charnwood Biomedical Campus.

More... »

Molecular Profiles joins consortium to drive pediatric formulation development

Thursday, January 2, 2014 10:30 AM

A collaborative pharmaceutical project focused on improving the pathway for developing pediatric formulations has been given the go-ahead after successfully securing an innovation grant.

More... »

BIA says E.U. Clinical Trial Regulation misses goal to make E.U. more attractive for trial conduct

Thursday, January 2, 2014 10:28 AM

The endorsement by the E.U. Committee of Permanent Representatives of the political agreement reached by the Lithuanian E.U. Council Presidency and the European Parliament, on the compromise text of the proposed E.U. Clinical Trials Regulation looks set to not deliver on the initial goal set by the European Commission (E.C.) when it launched the process in July 2012 of making the E.U. a more attractive location to conduct clinical trials.

More... »

EFPIA, PhRMA trial data sharing plan goes into effect

Thursday, January 2, 2014 10:22 AM

The European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Pharmaceutical Research and Manufacturers of America (PhRMA) have implemented the joint Principles for Responsible Clinical Trial Data Sharing.

More... »

NIHR researchers awarded $1M to search for Parkinson’s biomarkers

Friday, December 13, 2013 01:53 PM

Researchers from the National Institute for Health Research (NIHR) have secured a $1 million grant from research charity Parkinson's U.K. to search for elusive Parkinson's biomarkers. People with Parkinson's have an increased risk of approximately 80% to develop dementia.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs